{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:41:43Z","timestamp":1778643703734,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2811-B-002 -031"],"award-info":[{"award-number":["113-2811-B-002 -031"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX114-11407NI"],"award-info":[{"award-number":["NHRI-EX114-11407NI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["113-A-CC-5401-64841"],"award-info":[{"award-number":["113-A-CC-5401-64841"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30757-0","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T13:24:48Z","timestamp":1764422688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intraarterial microbubble delivery enhances focused ultrasound induced blood brain barrier opening in the murine substantia nigra"],"prefix":"10.1038","volume":"16","author":[{"given":"Hsun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En-Peng","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsin","family":"Ou-Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-I","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ya","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"30757_CR1","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.addr.2008.03.010","volume":"60","author":"K Hynynen","year":"2008","unstructured":"Hynynen, K. Ultrasound for drug and gene delivery to the brain. Adv. Drug Deliv Rev. 60, 1209\u20131217 (2008).","journal-title":"Adv. Drug Deliv Rev."},{"key":"30757_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biomaterials.2014.10.034","volume":"37","author":"H Yao","year":"2015","unstructured":"Yao, H. et al. Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system. Biomaterials 37, 345\u2013352 (2015).","journal-title":"Biomaterials"},{"key":"30757_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/17425247.2019.1567490","volume":"16","author":"D McMahon","year":"2019","unstructured":"McMahon, D., Poon, C. & Hynynen, K. Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability. Expert Opin. Drug Deliv. 16, 129\u2013142 (2019).","journal-title":"Expert Opin. Drug Deliv"},{"key":"30757_CR4","doi-asserted-by":"publisher","first-page":"eabj4011","DOI":"10.1126\/scitranslmed.abj4011","volume":"13","author":"Y Meng","year":"2021","unstructured":"Meng, Y. et al. MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases. Sci. Transl Med. 13, eabj4011 (2021).","journal-title":"Sci. Transl Med."},{"key":"30757_CR5","doi-asserted-by":"publisher","first-page":"N65","DOI":"10.1088\/0031-9155\/57\/7\/N65","volume":"57","author":"B Baseri","year":"2012","unstructured":"Baseri, B. et al. Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles. Phys. Med. Biol. 57, N65\u201381 (2012).","journal-title":"Phys. Med. Biol."},{"key":"30757_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jconrel.2023.04.041","volume":"358","author":"AE Aly","year":"2023","unstructured":"Aly, A. E. et al. Focused ultrasound enhances transgene expression of intranasal hGDNF DNA nanoparticles in the sonicated brain regions. J. Control Release. 358, 498\u2013509 (2023).","journal-title":"J. Control Release"},{"key":"30757_CR7","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1038\/s41467-024-48974-y","volume":"15","author":"HR Li","year":"2024","unstructured":"Li, H. R. et al. Engineering viral vectors for acoustically targeted gene delivery. Nat. Commun. 15, 4924 (2024).","journal-title":"Nat. Commun."},{"key":"30757_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","volume":"348","author":"K Ogawa","year":"2022","unstructured":"Ogawa, K. et al. Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain. J. Control Release. 348, 34\u201341 (2022).","journal-title":"J. Control Release"},{"key":"30757_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"30757_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/mds.27414","volume":"33","author":"SP Sardi","year":"2018","unstructured":"Sardi, S. P., Cedarbaum, J. M. & Brundin, P. Targeted therapies for parkinson\u2019s disease: from genetics to the clinic. Mov. Disord. 33, 684\u2013696 (2018).","journal-title":"Mov. Disord"},{"key":"30757_CR11","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/mds.29190","volume":"37","author":"Y Meng","year":"2022","unstructured":"Meng, Y. et al. Putaminal Recombinant glucocerebrosidase delivery with magnetic Resonance-Guided focused ultrasound in parkinson\u2019s disease: A phase I study. Mov. Disord. 37, 2134\u20132139 (2022).","journal-title":"Mov. Disord"},{"key":"30757_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/hum.2013.2527","volume":"25","author":"RG Crystal","year":"2014","unstructured":"Crystal, R. G. Adenovirus: the first effective in vivo gene delivery vector. Hum. Gene Ther. 25, 3\u201311 (2014).","journal-title":"Hum. Gene Ther."},{"key":"30757_CR13","first-page":"775","volume":"27","author":"JL Tyler","year":"1986","unstructured":"Tyler, J. L. et al. Pharmacokinetics of superselective intra-arterial and intravenous [11\u00a0C]BCNU evaluated by PET. J. Nucl. Med. 27, 775\u2013780 (1986).","journal-title":"J. Nucl. Med."},{"key":"30757_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/ANA.0b013e3181453851","volume":"19","author":"M Wang","year":"2007","unstructured":"Wang, M., Etu, J. & Joshi, S. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits. J. Neurosurg. Anesthesiol. 19, 249\u2013256 (2007).","journal-title":"J. Neurosurg. Anesthesiol"},{"key":"30757_CR15","first-page":"1755","volume":"20","author":"Y Arai","year":"1993","unstructured":"Arai, Y., Kido, C. & Ariyoshi, Y. [Pharmacokinetics in arterial infusion chemotherapy]. Gan Kagaku Ryoho. 20, 1755\u20131761 (1993).","journal-title":"Gan Kagaku Ryoho"},{"key":"30757_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3389\/fonc.2020.01443","volume":"10","author":"R Huang","year":"2020","unstructured":"Huang, R., Boltze, J. & Li, S. Strategies for improved Intra-arterial treatments targeting brain tumors: a systematic review. Front. Oncol. 10, 1443 (2020).","journal-title":"Front. Oncol."},{"key":"30757_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1148\/radiology.155.3.4001366","volume":"155","author":"C Charnsangavej","year":"1985","unstructured":"Charnsangavej, C. et al. Supraclinoid intracarotid chemotherapy using a flow-directed soft-tipped catheter. Radiology 155, 655\u2013657 (1985).","journal-title":"Radiology"},{"key":"30757_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/jnci\/80.2.84","volume":"80","author":"RL Dedrick","year":"1988","unstructured":"Dedrick, R. L. Arterial drug infusion: Pharmacokinetic problems and pitfalls. J. Natl. Cancer Inst. 80, 84\u201389 (1988).","journal-title":"J. Natl. Cancer Inst."},{"key":"30757_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/cn9000445","volume":"1","author":"R Chopra","year":"2010","unstructured":"Chopra, R., Vykhodtseva, N. & Hynynen, K. Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures. ACS Chem. Neurosci. 1, 391\u2013398 (2010).","journal-title":"ACS Chem. Neurosci."},{"key":"30757_CR20","doi-asserted-by":"publisher","first-page":"46689","DOI":"10.1038\/srep46689","volume":"7","author":"SK Wu","year":"2017","unstructured":"Wu, S. K. et al. Characterization of different microbubbles in assisting focused Ultrasound-Induced Blood-Brain barrier opening. Sci. Rep. 7, 46689 (2017).","journal-title":"Sci. Rep."},{"key":"30757_CR21","doi-asserted-by":"publisher","first-page":"617221","DOI":"10.3389\/fnins.2021.617221","volume":"15","author":"M Nesbit","year":"2021","unstructured":"Nesbit, M., Mamo, J. C., Majimbi, M., Lam, V. & Takechi, R. Automated quantitative analysis of ex vivo Blood-Brain barrier permeability using Intellesis Machine-Learning. Front. Neurosci. 15, 617221 (2021).","journal-title":"Front. Neurosci."},{"key":"30757_CR22","doi-asserted-by":"publisher","first-page":"25658","DOI":"10.1038\/srep25658","volume":"6","author":"R Villase\u00f1or","year":"2016","unstructured":"Villase\u00f1or, R. et al. Trafficking of endogenous Immunoglobulins by endothelial cells at the Blood-Brain barrier. Sci. Rep. 6, 25658 (2016).","journal-title":"Sci. Rep."},{"key":"30757_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0010-4825(97)00038-3","volume":"28","author":"A J\u00f6nsson","year":"1998","unstructured":"J\u00f6nsson, A. et al. Quantification of burn induced extravasation of Evans blue albumin based on digital image analysis. Comput. Biol. Med. 28, 153\u2013167 (1998).","journal-title":"Comput. Biol. Med."},{"key":"30757_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1160\/TH12-03-0196","volume":"108","author":"A von Drygalski","year":"2012","unstructured":"von Drygalski, A. et al. Infrared fluorescence for vascular barrier breach in vivo\u2013a novel method for quantitation of albumin efflux. Thromb. Haemost. 108, 981\u2013991 (2012).","journal-title":"Thromb. Haemost"},{"key":"30757_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s10571-006-9053-9","volume":"26","author":"E Weihe","year":"2006","unstructured":"Weihe, E., Depboylu, C., Sch\u00fctz, B., Sch\u00e4fer, M. K. & Eiden, L. E. Three types of tyrosine hydroxylase-positive CNS neurons distinguished by Dopa decarboxylase and VMAT2 co-expression. Cell. Mol. Neurobiol. 26, 659\u2013678 (2006).","journal-title":"Cell. Mol. Neurobiol."},{"key":"30757_CR26","doi-asserted-by":"publisher","first-page":"114539","DOI":"10.1016\/j.addr.2022.114539","volume":"190","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Ultrasound-mediated blood-brain barrier opening: an effective drug delivery system for theranostics of brain diseases. Adv. Drug Deliv Rev. 190, 114539 (2022).","journal-title":"Adv. Drug Deliv Rev."},{"key":"30757_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.ultrasmedbio.2007.04.006","volume":"33","author":"FY Yang","year":"2007","unstructured":"Yang, F. Y. et al. Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Ultrasound Med. Biol. 33, 1421\u20131427 (2007).","journal-title":"Ultrasound Med. Biol."},{"key":"30757_CR28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/annonc\/mdq576","volume":"22","author":"C Le P\u00e9choux","year":"2011","unstructured":"Le P\u00e9choux, C. et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003\u2009\u2013\u200908004, RTOG 0212 and IFCT 99\u2009\u2013\u200901). Ann. Oncol. 22, 1154\u20131163 (2011).","journal-title":"Ann. Oncol."},{"key":"30757_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/jum.14470","volume":"37","author":"H Li","year":"2018","unstructured":"Li, H. et al. Acoustic characterization and enhanced ultrasound imaging of Long-Circulating Lipid-Coated microbubbles. J. Ultrasound Med. 37, 1243\u20131256 (2018).","journal-title":"J. Ultrasound Med."},{"key":"30757_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1540-8175.1999.tb00144.x","volume":"16","author":"M Schneider","year":"1999","unstructured":"Schneider, M. Characteristics of sonovuetrade mark. Echocardiography 16, 743\u2013746. https:\/\/doi.org\/10.1111\/j.1540-8175.1999.tb00144.x (1999).","journal-title":"Echocardiography"},{"key":"30757_CR31","doi-asserted-by":"crossref","unstructured":"Hsu, Y. H. et al. Influence of acoustic parameters and sonication schemes on transcranial blood-brain barrier disruption induced by pulsed weakly focused ultrasound. Pharmaceutics. 14, 1207 (2022).","DOI":"10.3390\/pharmaceutics14061207"},{"key":"30757_CR32","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3171\/2017.11.FOCUS17627","volume":"44","author":"J Shin","year":"2018","unstructured":"Shin, J. et al. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters. NeuroSurg. Focus. 44, E15 (2018).","journal-title":"NeuroSurg. Focus"},{"key":"30757_CR33","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.7150\/thno.20621","volume":"7","author":"MA O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly, M. A. et al. Investigation of the safety of focused ultrasound-induced Blood-Brain barrier opening in a natural canine model of aging. Theranostics 7, 3573\u20133584 (2017).","journal-title":"Theranostics"},{"key":"30757_CR34","doi-asserted-by":"publisher","first-page":"100529","DOI":"10.1016\/j.rsurfi.2025.100529","volume":"19","author":"MMS Safiul Islam","year":"2025","unstructured":"Safiul Islam, M. M. S., Ahmed, M. A., Islam, N. & Hossain Mohammad Asaduzzaman Chowdhury, advances in nanoparticles in targeted drug delivery\u2013A review. Res. Surf. Interfaces. 19, 100529 (2025).","journal-title":"Results Surf. Interfaces"},{"key":"30757_CR35","doi-asserted-by":"publisher","first-page":"115199","DOI":"10.1016\/j.addr.2024.115199","volume":"206","author":"A Bouakaz","year":"2024","unstructured":"Bouakaz, A. & Michel Escoffre, J. From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research. Adv. Drug Deliv Rev. 206, 115199 (2024).","journal-title":"Adv. Drug Deliv Rev."},{"key":"30757_CR36","doi-asserted-by":"crossref","unstructured":"Norat, P. et al. Intraarterial transplantation of mitochondria after ischemic stroke reduces cerebral infarction. Stroke Vasc Interv Neurol 3 (2023).","DOI":"10.1161\/SVIN.122.000644"},{"key":"30757_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.mito.2017.03.004","volume":"34","author":"JD McCully","year":"2017","unstructured":"McCully, J. D., Cowan, D. B., Emani, S. M. & Del Nido, P. J. Mitochondrial transplantation: from animal models to clinical use in humans. Mitochondrion 34, 127\u2013134 (2017).","journal-title":"Mitochondrion"},{"key":"30757_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12964-024-01843-z","volume":"22","author":"M Zhao","year":"2024","unstructured":"Zhao, M. et al. Mitochondrion-based organellar therapies for central nervous system diseases. Cell. Commun. Signal. 22, 487 (2024).","journal-title":"Cell. Commun. Signal."},{"key":"30757_CR39","doi-asserted-by":"crossref","unstructured":"Andersen, S. B. et al. Super-resolution ultrasound imaging can quantify alterations in microbubble velocities in the renal vasculature of rats. Diagnostics (Basel) 12 (2022).","DOI":"10.3390\/diagnostics12051111"},{"key":"30757_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jconrel.2012.12.025","volume":"166","author":"F Yan","year":"2013","unstructured":"Yan, F. et al. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J. Control Release. 166, 246\u2013255 (2013).","journal-title":"J. Control Release"},{"key":"30757_CR41","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/pharmaceutics13111885","volume":"13","author":"JS Rechberger","year":"2021","unstructured":"Rechberger, J. S., Thiele, F. & Daniels, D. J. Status quo and trends of Intra-Arterial therapy for brain tumors: A bibliometric and clinical trials analysis. Pharmaceutics 13, 1885 (2021).","journal-title":"Pharmaceutics"},{"key":"30757_CR42","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.ultrasmedbio.2007.12.015","volume":"34","author":"N Sheikov","year":"2008","unstructured":"Sheikov, N., McDannold, N., Sharma, S. & Hynynen, K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol. 34, 1093\u20131104 (2008).","journal-title":"Ultrasound Med. Biol."},{"key":"30757_CR43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3171\/2010.9.JNS101223","volume":"114","author":"JA Boockvar","year":"2011","unstructured":"Boockvar, J. A. et al. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clin. Article J Neurosurg. 114, 624\u2013632 (2011).","journal-title":"Clin. Article J Neurosurg"},{"key":"30757_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11060-016-2099-8","volume":"128","author":"S Chakraborty","year":"2016","unstructured":"Chakraborty, S. et al. Superselective intraarterial cerebral infusion of cetuximab after osmotic blood\/brain barrier disruption for recurrent malignant glioma: phase I study. J. Neurooncol. 128, 405\u2013415 (2016).","journal-title":"J. Neurooncol"},{"key":"30757_CR45","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1208\/s12248-017-0076-6","volume":"19","author":"JJ Lochhead","year":"2017","unstructured":"Lochhead, J. J., Ronaldson, P. T. & Davis, T. P. Hypoxic stress and inflammatory pain disrupt Blood-Brain barrier tight junctions: implications for drug delivery to the central nervous system. AAPS J. 19, 910\u2013920 (2017).","journal-title":"AAPS J."},{"key":"30757_CR46","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jconrel.2021.07.042","volume":"337","author":"R Ji","year":"2021","unstructured":"Ji, R. et al. Cavitation-modulated inflammatory response following focused ultrasound blood-brain barrier opening. J. Control Release. 337, 458\u2013471 (2021).","journal-title":"J. Control Release"},{"key":"30757_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/362245a0","volume":"362","author":"M Kopf","year":"1993","unstructured":"Kopf, M. et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245\u2013248 (1993).","journal-title":"Nature"},{"key":"30757_CR48","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1084\/jem.175.4.973","volume":"175","author":"JM Purkerson","year":"1992","unstructured":"Purkerson, J. M. & Isakson, P. C. Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to Immunoglobulin (Ig) G1 and IgE. J. Exp. Med. 175, 973\u2013982. https:\/\/doi.org\/10.1084\/jem.175.4.973 (1992).","journal-title":"J. Exp. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30757-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30757-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30757-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:02:41Z","timestamp":1767888161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30757-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30757"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30757-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of the National Taiwan University Hospital (IACUC 20210059) and were conducted in accordance with the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"1030"}}